Skip to main content

UBS Group AG

Position in MCRB — Seres Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in MCRB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,818
-$58,536 QoQ
Shares Held
484
-93.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 36 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 31% Shared 0% None 69%

Common Shares in MCRB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. MCRB ranks #478 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MCRB

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,818 484
2026-03-31 $62,354 7,030
2025-12-31 $62,881 4,226
2025-09-30 $244,000 12,682
2025-06-30 $83,679 7,532
2025-03-31 $1,019,311 1,456,161
2024-12-31 $284,464 342,317
2024-09-30 $32,537 34,395
2024-06-30 $145,325 200,726
2024-03-31 $82,016 105,966
2023-12-31 $11,270 8,050
2023-09-30 $395,406 166,137
2023-06-30 $350,776 73,231
2023-03-31 $624,283 110,103
2022-12-31 $1,238,993 221,249
2022-09-30 $229,662 35,773
2022-06-30 $12,423 3,622
2022-03-31 $667,869 93,802
2021-12-31 $38,809 4,659
2021-09-30 $2,755,206 395,863
2021-06-30 $190,274 7,978
2021-03-31 $168,796 8,198
2020-12-31 $44,100 1,800
2020-09-30 $254,591 8,993
2020-06-30 $3,332 700
2020-03-31 $44,742 12,533